In vivo imaging approach to detect and quantify early fibrogenic remodeling following low-dose bleomycin exposure
IntroductionInterstitial lung diseases (ILDs) are a heterogeneous group of pulmonary disorders characterized by variable inflammation and fibrosis, leading to progressive impairment of gas exchange. Current therapeutic strategies rely on immunosuppressants and antifibrotics, but early diagnosis and...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2026-04-01
|
| coleção: | Frontiers in Pharmacology |
| Assuntos: | |
| Acesso em linha: | https://www.frontiersin.org/articles/10.3389/fphar.2026.1792856/full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|